Oramed Pharmaceuticals Inc.
USD4.69
+0.05 (+1.08%)
CEO
Nadav Kidron
IPO Date
2007-05-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.63
Prev. Close
$4.64
Day Low
$4.63
Day High
$4.74
52W Low
$1.98
52W High
$5.19
Market Cap
$0.19B
Volume
0.01M
| -5.2 |
| 31 Dec 2023 | FY | 100.0% | 412.3% | 3.4% | 2.5% | 0.32 | 3.06 | 16.9 |
| 31 Dec 2022 | FY | 100.0% | -1397.1% | -24.9% | -23.4% | 0.01 | 27.34 | -12.4 |
| 31 Aug 2021 | FY | 100.0% | -822.7% | -19.2% | -17.4% | 0.00 | 14.27 | -25.2 |
| 31 Aug 2020 | FY | 96.7% | -424.8% | -35.0% | -25.8% | 0.00 | 8.93 | -6.2 |
| 31 Aug 2019 | FY | 96.7% | -531.1% | -74.0% | -41.4% | 0.00 | 6.28 | -4.0 |
| 31 Aug 2018 | FY | 96.5% | -519.7% | -40.9% | -26.9% | 0.00 | 6.82 | -5.8 |
| 31 Aug 2017 | FY | 92.4% | -426.7% | -54.5% | -27.1% | 0.00 | 3.93 | -11.0 |
| 31 Aug 2016 | FY | 23.6% | -1710.5% | -41.9% | -25.6% | 0.00 | 8.62 | -8.3 |
| 2.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 23.8% | 21.9% | 0.00 | 22.24 | 0.6 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 8.6% | 8.2% | 0.01 | 26.81 | 1.8 |
| 31 Mar 2025 | Q1 | 0.7% | -382.1% | -5.4% | -5.2% | 0.00 | 23.94 | -2.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -7.0% | -6.6% | 0.00 | 25.19 | -2.4 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -12.5% | -11.9% | 0.00 | 27.08 | -1.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 5.2% | 5.0% | 0.00 | 41.06 | 2.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | 0.9% | 0.8% | 0.20 | 5.28 | 18.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 8.1% | 6.0% | 0.32 | 3.06 | 1.7 |